STATE STREET CORP - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 41 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,333
-34.2%
25,7740.0%0.00%
Q2 2023$29,382
-24.0%
25,7740.0%0.00%
Q1 2023$38,661
-49.7%
25,774
-50.0%
0.00%
Q4 2022$76,806
+92.0%
51,548
+100.0%
0.00%
Q3 2022$40,000
-32.2%
25,7740.0%0.00%
Q2 2022$59,000
-88.7%
25,774
-88.6%
0.00%
Q1 2022$521,000
-57.3%
225,572
+7.3%
0.00%
Q4 2021$1,220,000
-31.0%
210,292
+25.2%
0.00%
Q3 2021$1,768,000
+81.1%
168,031
+68.0%
0.00%
Q2 2021$976,000
+14.3%
100,000
+70.2%
0.00%
Q1 2021$854,00058,7710.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$580,0000.02%
Virtu Financial LLC 15,980$93,0000.01%
Jump Financial, LLC 11,800$68,0000.00%
Investment Research & Advisory Group, Inc. 1,400$4,0000.00%
Cubist Systematic Strategies, LLC 12,804$74,0000.00%
UBS Group AG 22,402$130,0000.00%
RHUMBLINE ADVISERS 18,894$110,0000.00%
Ellevest, Inc. 18$00.00%
TWO SIGMA INVESTMENTS, LP 28,771$167,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 11,105$64,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders